Richard Leigh-Pemberton

Late Stage Clinical Development
Bristol Myers Squibb

Dr Richard Leigh-Pemberton is an employee of Bristol Myers Squibb.

Poster(s):

• Design of a Phase 2, Randomized, Double-blind, Placebo-controlled Trial of BMS-986368, a Fatty Acid Amide Hydrolase/monoacylglycerol Lipase Inhibitor, for Spasticity Treatment in Multiple Sclerosis
  Tuesday, October 28, 2025

  12:15 PM - 12:30 PM